Selexipag

Red

Brand Name(s):Uptravi

Indication:Pulmonary arterial hypertension

Rationale:1,2

Considered:May-16

Review Date:May-26

Comments:
NHSE Clinical commissioning policy
Selexipag in an option for treating PAH
Dec 2018